Cure CF Columbus
  • Home
  • Core Services
    • Epithelial Cell
    • Immune
    • Translational
  • Training
  • Research
    • Grant Opportunities
    • Members
    • Pilot & Feasibility
    • Publications
  • Events
    • Events Archive

GRANT OPPORTUNITIES


Cure CF Columbus

Trainee Award Program

Request for Applications (2023-2024)

The grant includes two trainee fellowships. The purpose of this RFA is to support highly meritorious trainee projects. These applications can be an extension of prior funded C3 Research projects or new proposals from any eligible OSU or NCH trainee.
  • ​Up to $29,200 can be awarded to the trainee.
    • $25,000 will be used for partial stipend support from OSU.
    • $4,200 will be used for supplies, core services, animal costs, and travel and registration for the   North American CF Conference (NACFC). 
  • For trainees with prior C3 support, a second year of funding is contingent on demonstration of satisfactory progress and approval by the C3 Research Internal and External Advisory Boards. A separate budget and justification will be required at this stage. 
  • No indirect costs will be provided. 
RFA
RFA Release date: December 5, 2022
Grant Application Deadline: February 27, 2023 at 5pm
Award Notifications: May 2023
Earliest Project Start Date: July 1, 2023

Templates:

Budget
Budget Justification
Research Plan
Biosketch
Face PAge
SOW

Cure CF Columbus

Pilot & Feasibility Award​

Request for Applications (2023-2024)

Basic Science P&F Projects:
Funding of individual basic science P&F studies cannot extend beyond two years. Year 1 funding ($40,000) will be provided by C3 after completion of the review process.  The second year of funding ($40,000) is contingent upon submission and approval of a renewal progress report and the availability of funds.  No indirect costs will be provided.      
 
Translational P&F Projects:
These projects seek to apply basic scientific knowledge to a clinical problem, acquire basic knowledge from clinical specimens, or examine the feasibility of a therapeutic approach in an appropriate animal model or with appropriate clinical specimens. Translational P&F projects may receive funding for up to two years. Year 1 funding ($60,000) will be provided by C3 after completion of the review process. Year 2 funding ($60,000) is contingent upon submission and approval of a renewal progress report and the availability of funds. No indirect costs will be provided. 
 
Translational P&F projects may not subject human volunteers to experimental medicines, devices or techniques; obtain clinical specimens prospectively unless such specimens are collected as a part of routine patient care; or make use of Health Insurance Portability and Accountability Act-protected confidential patient information. 
 
Direct costs may be requested for:
  • Salary support
  • Research supplies
  • Equipment
  • Research-related subject costs
  • Consultant costs
  • Support for multidisciplinary collaborations, including travel
  • Travel costs for scientific/technical meeting(s)
RFA
RFA Release date: December 5, 2022
Grant Application Deadline: February 27, 2023 at 5pm
Award Notifications: May 2023
Earliest Project Start Date: July 1, 2023

Templates:

Budget
Budget Justification
Research Plan
Biosketch
Face Page
SOW

Cure CF Columbus

Trainee Award Program

Phase 3 Request for Applications (2019-2020)

The call for applications is now closed.
Award Notification: Late February, 2020
HOME  |  CORE SERVICES  |  TRAINING PROGRAM  |  RESEARCH  |  EVENTS
Cure CF Columbus
​©2019. All Rights Reserved.
  • Home
  • Core Services
    • Epithelial Cell
    • Immune
    • Translational
  • Training
  • Research
    • Grant Opportunities
    • Members
    • Pilot & Feasibility
    • Publications
  • Events
    • Events Archive